Literature DB >> 8321849

Disposition characteristics of protein drugs in the perfused rat kidney.

K Mihara1, T Hojo, M Fujikawa, Y Takakura, H Sezaki, M Hashida.   

Abstract

The renal disposition characteristics of 111In-labeled neocarzinostatin (NCS), soybean trypsin inhibitor (STI), and superoxide dismutase (SOD) were studied in the perfused rat kidney. In a single-pass indicator dilution experiment, venous and urinary recovery profiles and tissue accumulation of proteins were determined under filtering or nonfiltering conditions. In the nonfiltering kidney perfusion experiment, no significant tissue accumulation was observed, suggesting minimal uptake from the glomerular and peritubular capillary sides. Therefore, tissue recovery corresponded to that with tubular reabsorption after glomerular filtration. The total amount of NCS or STI being filtrated through glomeruli, the sum of tissue and urinary recoveries, was similar to that of inulin, but that of SOD was about half. Similarly, the steady-state distribution volumes (Vd) of NCS and STI obtained by moment analysis of their venous outflow curves were similar to that of inulin, while the Vd value of SOD was significantly lower. These results suggest the restricted passage of SOD through the glomerular and postglomerular capillary wall. The tubular reabsorption ratio of proteins against the total filtrated amount decreased with an increase in the administered dose, suggesting nonlinearity of reabsorption. SOD had the largest reabsorption ratio. Thus, this experimental system is useful for quantitative analysis of renal disposition of proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321849     DOI: 10.1023/a:1018996808153

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

Review 1.  Metabolism of protein anticancer agents.

Authors:  V Bocci
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

Review 2.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

3.  A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.

Authors:  T Kakutani; K Yamaoka; M Hashida; H Sezaki
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

4.  Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.

Authors:  S Hall; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

5.  Renal metabolism of calcitonin.

Authors:  R E Simmons; J T Hjelle; C Mahoney; L J Deftos; W Lisker; P Kato; R Rabkin
Journal:  Am J Physiol       Date:  1988-04

6.  Improved function with amino acids in the isolated perfused kidney.

Authors:  F H Epstein; J T Brosnan; J D Tange; B D Ross
Journal:  Am J Physiol       Date:  1982-09

7.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  Disposition characteristics of model macromolecules in the perfused rat kidney.

Authors:  K Mihara; M Mori; T Hojo; Y Takakura; H Sezaki; M Hashida
Journal:  Biol Pharm Bull       Date:  1993-02       Impact factor: 2.233

9.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

10.  Determination of postglomerular permselectivity to neutral dextrans in the dog.

Authors:  C Whiteside; M Silverman
Journal:  Am J Physiol       Date:  1983-10
View more
  5 in total

1.  Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney.

Authors:  A Takagi; Y Yabe; Y Oka; K Sawai; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  Characterization of LLC-PK1 kidney epithelial cells as an in vitro model for studying renal tubular reabsorption of protein drugs.

Authors:  Y Takakura; T Morita; M Fujikawa; M Hayashi; H Sezaki; M Hashida; R T Borchardt
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor.

Authors:  Kazuhiro Fukuta; Kunio Matsumoto; Toshikazu Nakamura
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.

Authors:  M Nishikawa; H Hirabayashi; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

5.  Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Authors:  Hidemasa Katsumi; Jun-Ichi Sano; Makiya Nishikawa; Keiko Hanzawa; Toshiyasu Sakane; Akira Yamamoto
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.